
GC64566
PF-06454589
Also known as 4-[5-(1-methylpyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]morpholine
PF-06447475 is a highly potent, selective, brain penetrant LRRK2 kinase inhibitor with IC50 values of 3 nM and 11 nM for WT LRRK and G2019S LRRK2, respectively
ChemicalCAS1527473-30-8MW284.32FormulaC14H16N6O
- CAS number
- 1527473-30-8
- Molecular weight
- 284.32
- Formula
- C14H16N6O
- Solubility
- DMSO : 15·62 mg/mL (54·94 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- VNWKCLDQBNSJJO-UHFFFAOYSA-N
- Catalogue number
- GC64566
- Brand
- GLPBIO
Computed properties PubChem CID 72706837 · XLogP 0.7 · TPSA 71.9 Ų · H-bond donors 1
- XLogP
- 0.7
- TPSA
- 71.9 Ų
- H-bond donors
- 1
- H-bond acceptors
- 5
- Rotatable bonds
- 2
- Heavy atoms
- 21
SMILES CN1C=C(C=N1)C2=CNC3=C2C(=NC=N3)N4CCOCC4
Computed descriptors from PubChem (CID 72706837), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il